Tag: Huntington’s gene therapy efficacy data 2024
Huntington’s Disease Gene Therapy 2024: US Clinical Trials, FDA Approval Timeline, Efficacy Data, Cost Estimates & Rare Neurodegenerative Pipeline Updates
Updated October 2024, this FDA, NINDS, and NORD-verified 2024 Huntington’s disease gene therapy buying guide covers the latest US clinical trials, FDA approval timeline, efficacy data, cost estimates, and rare neurodegenerative pipeline updates. Our premium FDA-regulated candidates vs unregulated counterfeit overseas models comparison highlights 8 active US trials, with leading therapy AMT-130 delivering 75% slower